News

Cambridge Network46m
Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
Qureight’s AI-powered analytics technologies are specialised towards interstitial lung diseases such as IPF. The company’s ...
Cambridge Network50m
Source Genomics X Cambridge Clinical Laboratories launch event
The Source Genomics X Cambridge Clinical Laboratories launch event took place on Thursday 10th July at the Cambridge facility ...